Search the Newsreel

Lucid's EsoGuard Is the Only Esophageal Precancer Test Meeting Coverage Criteria

Lucid Diagnostics (Nasdaq: LUCD) announced that Concert, a healthcare technology company recently acquired by Lyric, issued a positive commercial coverage policy for its EsoGuard Esophageal DNA Test, effective July 2026. This policy deems EsoGuard medically necessary for non-invasive screening of esophageal precancer and cancer …

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test

Lucid Diagnostics Inc. announced that Concert, a healthcare technology company, has issued a positive coverage policy for its EsoGuard® Esophageal DNA Test. This policy, effective July 2026, recognizes EsoGuard as medically necessary for non-invasive screening of esophageal precancer and cancer in patients meeting ACG …

Lucid Diagnostics to Participate in Upcoming Investor Conferences

Lucid Diagnostics Inc. announced its participation in two upcoming investor conferences: the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 10, 2026, and the Canaccord Genuity 46th Annual Growth Conference on August 11, 2026. Management will hold 1x1 meetings and a …

Lucid Diagnostics Sets Boston Fireside Chat and Virtual Meetings

Lucid Diagnostics (Nasdaq: LUCD), a cancer prevention diagnostics company and subsidiary of PAVmed (Nasdaq: PAVM), announced its participation in two upcoming investor events. Management will attend the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 10, 2026, and host a fireside …

Earnings Flash (LCID) Lucid Group, Inc. Reports Q2 Revenue $405.3M, vs. FactSet Est of $381.6M

Lucid’s (NASDAQ:LCID) Q2 CY2026 Sales Beat Estimates But Stock Drops

Lucid Heads Into Earnings After Best Month Of 2026 — Saudi-Fueled Rally Faces Reality Check As Wall Street Sees Nearly $900M Loss

Lucid Group (LCID) is set to release its Q2 2026 earnings after experiencing its best month of the year, driven by recent Saudi investments. However, the company faces forecasts of a substantial nearly $900 million net loss. Investors will be keenly watching for updated …

Rosen Law Firm Urges Lucid Group, Inc. (NASDAQ: LCID) Stockholder

Rosen Law Firm has announced a class action lawsuit against Lucid Group, Inc. (NASDAQ: LCID) on behalf of investors who purchased securities between February 25, 2026, and April 13, 2026. The lawsuit alleges that Lucid Group made false and misleading statements by failing to …

Lucid Group (NASDAQ:LCID) Stock Price Up 4.3% - Time to Buy?

Lucid Group (NASDAQ:LCID) stock price increased by 4.3% to $7.70 on Monday, although trading volume was lower than average. Analyst sentiment remains largely negative with a consensus "Reduce" rating and an average price target of $9.56. Institutional investors, including Goldman Sachs and AQR Capital …

Lucid Group, Inc. Revenue Breakdown – DUS:CH2

This article provides a revenue breakdown for Lucid Group, Inc. (CH2) from the Dusseldorf Stock Exchange. It highlights that the company generated 1.15 billion EUR last year, primarily from its Electric Vehicle segment, with the United States being the largest contributing region.

Cantor Fitzgerald reiterates Neutral on Lucid stock ahead of earnings By Investing.com

Cantor Fitzgerald has maintained a Neutral rating and an $8.00 price target for Lucid Group Inc. (NASDAQ:LCID) in anticipation of its second-quarter earnings report. Despite challenges like lower-than-expected vehicle deliveries, negative gross margins, and a net loss, the stock has recently seen a gain, …

Why Luceco (LSE:LUCE) Is Drawing Fresh Attention Among UK Growth Stocks

Lucid (LCID) Q2 Earnings Report Preview: What To Look For

Lucky Strike Entertainment (NYSE:LUCK) Given Consensus Rating of "Hold" by Brokerages

Lucky Strike Entertainment (NYSE:LUCK) has received a consensus "Hold" rating from thirteen brokerages, with an average 12-month price target of $8.72, compared to its recent price of $7.00. The company recently missed quarterly earnings and revenue expectations and announced a quarterly dividend of $0.06. …

Luceco PLC Revenue Breakdown – DUS:2LC

Luceco PLC Revenue Breakdown – LSE:LUCE

Lucid Group (NASDAQ:LCID) Stock Price Down 7.7% - What's Next?

Lucid Group (NASDAQ:LCID) stock fell 7.7% to $7.4950 on Friday, with trading volume significantly below average, as investors await its August 4th earnings report. The company faces ongoing concerns about its cash position, production, demand, and execution challenges, intensified by a broader EV-sector selloff …

Lucid Shares Down 96% In Five Years

Lucid's stock has plummeted 96% over the last five years, with bankruptcy discussions surfacing despite a recent $129.5 million investment from Saudi Prince Alwaleed. The EV company reported a net loss of over $1 billion in Q1 on $282 million in revenue, delivering only …

Enterprise value to revenue forward of Lucky Strike Entertainment Corporation – NYSE:LUCK

AJ Lucas Reports $24.0 Million Quarterly Australian Revenue as Coal Drilling Demand Softens

Lucid Group Number of Employees 2026 | Employee Count & Headcount Data

Lucid Group, Inc. (LCID) has approximately 8,880 employees worldwide as of March 2026, marking a 29.6% growth since 2023. The company is actively hiring, with 521 job postings in 2026, though this represents a decline from previous years. The workforce is primarily concentrated in …

Lucid Diagnostics CEO and CFO to Discuss Operations Aug. 13

Lucid Diagnostics (Nasdaq: LUCD) will host a second quarter 2026 business update conference call and webcast on Thursday, August 13, 2026, at 8:30 AM ET. CEO Lishan Aklog, M.D. and CFO Dennis McGrath will discuss business operations, growth strategy, and financial results. Investors can …

Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026

Lucid Diagnostics (Nasdaq: LUCD) will host a business update conference call and webcast on Thursday, August 13, 2026, at 8:30 AM ET. Chairman and CEO Lishan Aklog, M.D., will provide a business update and discuss the company's operations and growth strategy, while CFO Dennis …

Saudi billionaire takes $127M stake in EV maker Lucid

Prince Alwaleed bin Talal Al Saud has acquired a 5% stake in electric vehicle manufacturer Lucid Group Inc. for $127 million. This investment comes as Lucid restructures and implements cost-cutting measures. Following the disclosure, Lucid's shares experienced a significant surge, despite having lost approximately …

Is Lucid Stock a Buy After Prince Al Waleed Takes 19.5M Share Stake?

Prince Al Waleed bin Talal Al Saud has acquired a 19.5-million-share stake in Lucid Group (NASDAQ:LCID) as a passive investment, causing initial excitement followed by profit-taking. Despite a premarket dip, LCID stock is still trading above its 20-day and 50-day SMAs, indicating some bullish …

Lucid Diagnostics Inc (LUCD) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Lucid Diagnostics Inc (LUCD), detailing its price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. The stock's current price momentum score is 4.57, ranking 75th in its industry, trading between …

Saudi capital doubles down on new energy: Lucid receives $130 million investment from the kingdom's richest man

Saudi Prince Alwaleed bin Talal Al Saud has invested approximately $129.5 million in Lucid Group, acquiring about 5% of the company's equity during a period of significant stock price decline. This investment comes shortly after Lucid denied bankruptcy rumors but confirmed hiring restructuring advisors. …

Lucid Group (LCID) Soars 21% as Saudi Prince Backing Eases Financial Health Worries

Lucid Group (LCID) saw its stock price increase by over 21% after a Saudi Prince, Alwaleed Bin Talal Bin Abdulaziz, acquired a 5% stake in the company, amounting to $154 million. This investment helped alleviate concerns regarding the electric vehicle maker's financial stability, especially …

LCID UPCOMING DEADLINE : The Gross Law Firm Alerts Lucid Group, Inc. Stockholders of Securities Class Action - Contact the Firm

The Gross Law Firm has issued a notice to stockholders of Lucid Group, Inc. (NASDAQ: LCID) concerning a securities class action lawsuit. Investors who purchased shares between February 25, 2026, and April 13, 2026, are encouraged to contact the firm regarding potential lead plaintiff …

HRH Prince Alwaleed discloses 5% Lucid Group (LCID) ownership with 19.5M shares

HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud has reported a 5% beneficial ownership stake in Lucid Group, Inc. (LCID) Class A common stock, totaling 19,513,000 shares. This ownership gives him sole voting and dispositive power over these shares. The filing, a Schedule 13G, …

Lucid Group Shares Rise After HRH Prince Alwaleed Discloses 5% Stake

Lucid Group (LCID) shares increased by nearly 2.4% after HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud disclosed a 5% stake in the company. The article, however, requires a premium subscription to view the full details of this development.

Analysts Estimate Lucid Group (LCID) to Report a Decline in Earnings: What to Look Out for

Earnings Flash (LUCE.L) Luceco PLC Reports H1 Revenue GBP143.0M

Luceco Raises Profit Forecast as Energy Transition Business Delivers Strong Growth

Deadline Soon: Lucid Group, Inc. (LCID) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz is reminding Lucid Group, Inc. (LCID) investors of the July 28, 2026, deadline to participate as a lead plaintiff in a securities fraud class action lawsuit. The lawsuit alleges that Lucid made misleading statements and failed to …

LUCD|Lucid Diagnostics Inc|Price:0.923|Chg%:+0.019

TradingKey provides a comprehensive stock analysis for Lucid Diagnostics Inc (LUCD), highlighting its "fairly valued" status with high institutional ownership and strong fundamentals despite recent weak stock market performance. The company, which specializes in medical diagnostics for esophageal precancer and cancer with products like …